Pharmaceuticals

Non-Steroidal Anti-inflammatory Drugs Market Growth Opportunities: Insights from 2025–2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Anticipated Size Of The Non-Steroidal Anti-inflammatory Drugs Market Over The Five-Year Period 2025–2029?

The non-steroidal anti-inflammatory drugs market has experienced robust growth over recent years. This market is anticipated to expand from $20.68 billion in 2024 to $21.89 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.8%. The historical growth in this sector is largely due to factors including chronic inflammatory diseases, postoperative pain management, sports injuries, the availability of these drugs over-the-counter, an aging population, and increased consumer awareness.

The non-steroidal anti-inflammatory drugs market size is anticipated to undergo significant expansion over the next few years. It is forecast to grow to $28.15 billion in 2029, achieving a compound annual growth rate (CAGR) of 6.5%. This growth during the projection period can be attributed to several factors including evolving pain management therapies, regulatory adjustments, increased telehealth adoption, worldwide wellness trends, biosimilar rivalry, shifts in patient preferences, and personalized medicine strategies. Prominent trends for the forecast period encompass the dominance of the over-the-counter (OTC) market, a rising preference for cox-2 inhibitors, the influence of generics and market competition, and the integration of digital health technologies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8023&type=smp

Which Industry Drivers Are Expected To Accelerate The Non-Steroidal Anti-inflammatory Drugs Market From 2025 To 2029?

An increasing prevalence of chronic pain is anticipated to stimulate the expansion of the non-steroidal anti-inflammatory drugs market moving forward. Chronic pain is defined as persistent discomfort lasting beyond six months. Non-steroidal anti-inflammatory drugs are employed to alleviate injuries and address chronic pain. For example, in April 2022, a report from the CDC (Centers for Disease Control and Prevention), a US-based government agency, revealed that chronic pain frequently stemmed from arthritis, a condition affecting millions of people across the US. Approximately one in four adults among 15 million individuals with arthritis experience severe joint pain attributed to the condition. Thus, the escalating incidence of chronic pain is propelling the growth of the non-steroidal anti-inflammatory drugs market.

What Are The Segment Types Shaping The Non-Steroidal Anti-inflammatory Drugs Market?

The non-steroidal anti-inflammatory drugs market covered in this report is segmented –

1) By Route Of Administration: Oral, Topical, Other Route Of Administration

2) By Disease Indication: Arthritis, Migraine, Ophthalmic Diseases, Other Disease Indications

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Oral: Tablets, Capsules, Liquids Or Solutions

2) By Topical: Gels, Creams, Patches

3) By Other Route Of Administration: Injectable (Intravenous And Intramuscular), Suppositories

What Are The Latest Industry Trends Transforming The Non-Steroidal Anti-inflammatory Drugs Market?

Product innovation represents a significant development in the non-steroidal anti-inflammatory drugs market. Major companies operating in the non-steroidal anti-inflammatory drugs market are focusing on developing new technological solutions. For instance, in March 2024, Endo International plc, an Ireland-based pharmaceutical company, introduced ibuprofen-famotidine 800 mg/26.6 mg tablets. Ibuprofen-famotidine 800 mg/26.6 mg tablets integrate the pain-relieving and anti-inflammatory properties of ibuprofen with the gastroprotective benefits of famotidine. This unique formulation is engineered to relieve pain while simultaneously reducing the likelihood of gastrointestinal side effects commonly linked to the extended use of nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen.

Which Industry Leaders Are Driving Innovation Across The Non-Steroidal Anti-inflammatory Drugs Market?

Major companies operating in the non-steroidal anti-inflammatory drugs market are Pfizer Inc., Bayer AG, Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Assertio Therapeutics Inc., Iroko Pharmaceuticals Inc., Reckitt Benckiser Group PLC, Perrigo Company PLC, Hikma Pharmaceuticals Public Limited Company, Glenmark Pharmaceuticals Limited, Septodont, Aspen Pharmacare Holdings Limited, Sagent Pharmaceuticals Inc., Advanced Pharma Inc., Akorn Operating Company LLC, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Lupin Limited, Cipla Limited, Zydus Cadila Healthcare Limited, Aurobindo Pharma Limited, Sanofi S.A., GlaxoSmithKline PLC, Horizon Therapeutics PLC, Zyla Life sciences, Novartis AG, Roche Holding AG, AbbVie Inc., Bristol-Myers Squibb Company

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report

Which Region Currently Holds The Largest Share Of The Non-Steroidal Anti-inflammatory Drugs Market?

North America was the largest region in the non-steroidal anti-inflammatory drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the non-steroidal anti-inflammatory drugs market during the forecast period. The regions covered in the non-steroidal anti-inflammatory drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Non-Steroidal Anti-inflammatory Drugs Market Report:

https://www.thebusinessresearchcompany.com/customise?id=8023&type=smp

Browse Through More Reports Similar to the Global Non-Steroidal Anti-inflammatory Drugs Market 2025, By The Business Research Company

Corticosteroid Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/corticosteroid-global-market-report

Antiemetics And Antinauseants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

Inflammatory Bowel Disease Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795